ABOUT US
There are more than 9 million immunocompromised people in the United States. Almost half a million of those represent a population that are moderately to severely immunocompromised and at highest risk for severe COVID-19, including stem cell and solid organ transplant patients as well as those with hematologic cancers.
At Invivyd, Inc., we take those numbers very seriously and we come to work each day on a mission to deliver protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies.
In March 2024 , Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates.
In October 2025 , the FDA cleared the company's Investigational New Drug (IND) application and provided feedback to advance the company's REVOLUTION clinical program, Invivyd's development program for VYD2311, a vaccine alternative monoclonal antibody being investigated for the prevention of COVID-19.
Be part of making a difference. Be part of Invivyd.
Location: Remote, US
Position Summary:
The Senior Director, Strategic IDNs & Health System Access is a senior commercial leader responsible for developing and executing the organization's national Integrated Delivery Network (IDN), health system, and institutional market access strategy. Reporting to the US Head of Market Access, this role serves as the strategic leader of the Integrated Delivery System Account Directors (IDN NADs) for health system access, contracting, reimbursement, and account engagement across major national and regional IDNs, academic medical centers, and integrated healthcare organization.
The individual will combine enterprise-level strategic leadership with deep institutional account expertise to ensure optimal patient access, formulary adoption, policy development, reimbursement, and utilization across complex provider systems. This leader will build and lead a high-performing team of Account Directors, while partnering closely with the Payer Account Team as well as Sales, Marketing, Medical Affairs, HEOR, Trade & Distribution, Government Affairs, Patient Services, and Legal to create and execute access strategies that maximize patient access and long-term portfolio value.
The ideal candidate is a highly strategic, externally focused market access executive with extensive experience navigating complex health system environments, executing contracting strategies, influencing institutional decision-makers, and leading cross-functional organizations through launch and growth phases.
Responsibilities:
Strategic Leadership & Health System Market Access
Develop and execute the national IDN and health system access strategy aligned with corporate and commercial objectives
Establish long-term strategic plans to optimize formulary positioning, coverage, reimbursement, and utilization across major integrated health systems
Assess evolving healthcare delivery models, institutional economics, site-of-care trends, and reimbursement dynamics to identify opportunities and risks
Serve as the executive subject matter expert on IDN market access trends and institutional channels
Provide strategic recommendations to executive leadership regarding contracting, pricing, access, and channel strategies
Lead health system readiness planning for current and future portfolio assets and support successful product launches
Contracting, Reimbursement & Channel Optimization
Lead institutional contracting strategy and oversee negotiations across major health systems and organized provider networks
Guide contracting decisions that optimize access, utilization, profitability, and long-term customer value
Direct strategies involving buy-and-bill distribution, medical benefit reimbursement, pharmacy benefit management, ASP-based reimbursement, WAC…